Percentile curve of distress scores as a clinical aid for the evaluation and management of cancer patient's distress

Bergerot, Cristiane Decat; Tróccoli, Bartholomeu Tôrres; Philip, Errol J.; Buso, Marco Murilo

doi:10.1002/pon.3507

Cited by 2 publications

(13 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For those with higher anxiety and depression scores identified at baseline, they often still have such scores at the end of therapy. Previous studies conducted in LMICs with patients newly diagnosed with cancer identified a similar pattern, with a high prevalence of symptoms of anxiety and depression at baseline that tend to decrease over time 6,7 . However, there is some evidence that distress can endure into survivorship for a substantial percentage of patients, 25,26 which is consistent with these findings.…”

Section: Discussionsupporting

confidence: 74%

“…Previous studies have noted that emotional distress (anxiety and depression) tends to lessen over time for many patients in United States, Europe (e.g., London, Sweden and Netherland) and also in Brazil 6,7,14–16,21–24 . However, despite the fact that the current study noted a similar trend in Brazil, by the end of the chemotherapy treatment, there were still a great number of patients experiencing moderate to severe distress.…”

Section: Discussioncontrasting

confidence: 71%

“…Evidence suggests that screening should be performed at critical time points, including at diagnosis; the start, middle and end of treatment; survivorship; at the time of disease recurrence or progression; and at the end of life, to help guide treatment and planning 1,4,5 . Routine screening can help guide the development and implementation of effective supportive services and gain insight into specific risk factors associated with distress among patients 5,6 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Association between hospital anxiety and depression scale and problem‐related distress in patients with cancer in a Brazilian private institution

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objective Emotional symptoms are frequently reported among patients with cancer. We evaluated the association between emotional symptoms and problem‐related distress in a sample of patients with cancer about to initiate chemotherapy within a private hospital in Brazil. Methods Patients were assessed before initiating chemotherapy, treatment mid‐point, and on the last day of treatment for anxiety and depression (Hospital Anxiety and Depression Scale [HADS]) and for problem‐related distress (Distress Thermometer Problem List). Problem‐related distress variable was computed as the sum of practical, physical, spiritual and familial problems. Mixed‐model analysis was applied to determine the association between HADS and problem‐related distress, adjusting for age and gender. Results A total of 655 consecutive patients were enrolled. There was a significant main effect of time (F = 8.99, p = 0.0001), showing that emotional symptoms improve over time. A significant main effect was observed for problem‐related distress (F = 371.56, p < 0.0001) revealing that patients with elevated problem‐related distress at baseline tend to have higher HADS across the three time points, compared to patients with lower problem‐related distress. There was an interaction effect between problem‐related distress and time (F = 85.22, p < 0.0001), suggesting that HADS scores decreased differently over time, depending on patients' initial level of problem‐related distress. Conclusion Overall, emotional symptoms, while decreasing over time, remained associated with problem‐related distress after chemotherapy in Brazil. The potential benefit of implementing a psychosocial intervention remains high throughout cancer treatment.

show abstract

Section: Discussionsupporting

confidence: 74%

Section: Discussioncontrasting

confidence: 71%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association between hospital anxiety and depression scale and problem‐related distress in patients with cancer in a Brazilian private institution

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Eventualmente, alguns artigos abrangeram mais de uma categoria. Na primeira categoria, verificaram-se os estudos sobre instrumentos capazes de identificar e/ou medir o distress em pacientes oncológicos 9,11,14,17 . Em dois estudos 9,14 , a medição do distress foi realizada por meio do distress thermometer (DT) e em outro estudo 11 , além do DT, o instrumento Hospital Anxietyand Depression Scale (HADS) foi associado para medir o distress em pacientes oncológicos.…”

Section: Resultsunclassified

“…Na primeira categoria, verificaram-se os estudos sobre instrumentos capazes de identificar e/ou medir o distress em pacientes oncológicos 9,11,14,17 . Em dois estudos 9,14 , a medição do distress foi realizada por meio do distress thermometer (DT) e em outro estudo 11 , além do DT, o instrumento Hospital Anxietyand Depression Scale (HADS) foi associado para medir o distress em pacientes oncológicos. Apenas um estudo utilizou o MD Anderson Sympton Inventary (MDASI) -core para identificar o distress nos pacientes em tratamento oncológico 17 .…”

Section: Resultsunclassified

Distress em Pacientes Oncológicos no Brasil: Revisão Integrativa da Literatura

Perdigão

Rodrigues

Carvalho

et al. 2022

Rev. Bras. Cancerol.

View full text Add to dashboard Cite

Introdução: O paciente oncológico vivencia uma série de mudanças em sua vida diante do diagnóstico e do tratamento, sendo o aspecto emocional um dos atingidos nesse processo. O termo "distress" foi escolhido para se referir ao sofrimento emocional vivenciado pelo paciente oncológico. Objetivo: Identificar como o distress em pacientes oncológicos tem sido abordado em estudos realizados no Brasil. Método: Revisão integrativa da literatura científica sobre o distress realizada em setembro de 2020. Para a busca nas bases de dados, utilizaram-se o descritor "Neoplasias" e o termo "Distress". Foram selecionados artigos disponíveis na íntegra publicados em português, inglês ou espanhol, tendo como assunto país/Região: Brasil, sem corte temporal, nas bases de dados LILACS, MEDLINE e BDENF. Foi realizada a etapa de leitura crítica para análise e síntese dos artigos. Os artigos selecionados foram organizados e apresentados na forma de quadro e a interpretação dos resultados em categorias. Resultados: A amostra final desta revisão resultou em nove artigos que apontaram instrumentos capazes de identificar e/ou medir o distress, discorreram sobre os fatores associados à presença do distress e os fatores que impactaram na redução dos distress. Conclusão: O paciente com câncer pode vivenciar o distress em qualquer fase da doença. Diante da escassez de artigos acerca do distress no cenário brasileiro, recomenda-se que se desenvolvam mais estudos a fim de aprofundar e consubstanciar a temática. Palavras-chave: neoplasias/psicologia; angústia psicológica; literatura de revisão como assunto; Brasil.

show abstract

Percentile curve of distress scores as a clinical aid for the evaluation and management of cancer patient's distress

Cited by 2 publications

References 13 publications

Association between hospital anxiety and depression scale and problem‐related distress in patients with cancer in a Brazilian private institution

Association between hospital anxiety and depression scale and problem‐related distress in patients with cancer in a Brazilian private institution

Distress em Pacientes Oncológicos no Brasil: Revisão Integrativa da Literatura

Contact Info

Product

Resources

About